Antabio Implement Web-based Informatics Solution to Facilitate Global Collaborations 2019Case Study: Antabio Implement Web-based Informatics Solution to Facilitate Global Collaborations 2 Antabio is a private biopharmaceutical company developing a broad pipeline of novel antibacterial treatments focused on drug-resistant life threatening infections. All Antabio programs address WHO critical priority pathogens and are eligible for streamlined development. Founded in 2009 by Marc Lemonnier, Antabio has built a best in class, international team with highly successful track records including former executives from Novexel, Galapagos, Merck, GSK and Astra Zeneca. The company is headquartered near Toulouse, France and has UK and US subsidiaries. Martin has over 25 years’ experience

Join for free to read